Low early ototoxicity rates for pediatric medulloblastoma patients treated with proton radiotherapy

BACKGROUND: Hearing loss is common following chemoradiotherapy for children with medulloblastoma. Compared to photons, proton radiotherapy reduces radiation dose to the cochlea for these patients. Here we examine whether this dosimetric advantage leads to a clinical benefit in audiometric outcomes....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Moeller, Benjamin J, Chintagumpala, Murali, Philip, Jimmy J, Grosshans, David R, McAleer, Mary F, Woo, Shiao Y, Gidley, Paul W, Vats, Tribhawan S, Mahajan, Anita
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2011
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3123575/
https://ncbi.nlm.nih.gov/pubmed/21635776
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1748-717X-6-58
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados